Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil
- 1 January 2007
- journal article
- clinical trial
- Published by Elsevier BV in Kidney International
- Vol. 71 (1), 24-30
- https://doi.org/10.1038/sj.ki.5001870
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Late and early C4d-positive acute rejection: Different clinico-histopathological subentities in renal transplantationKidney International, 2006
- Intravenous Immunoglobulin and Plasmapheresis in Acute Humoral Rejection: Experience in Renal Allograft TransplantationHuman Immunology, 2005
- Effects of mycophenolate mofetil on donor‐specific antibody formation in renal transplantationClinical Transplantation, 2005
- Acute tubular necrosis is characterized by activation of the alternative pathway of complementKidney International, 2005
- Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection1Transplantation, 2003
- Humoral rejection in kidney transplantation: new concepts in diagnosis and treatmentCurrent Opinion in Nephrology and Hypertension, 2002
- C4d staining of perioperative renal transplant biopsies1Transplantation, 2002
- The humoral immune response towards HLA class II determinants in renal transplantationKidney International, 1996
- REDUCED HUMAN IgG ANTI-ATGAM ANTIBODY FORMATION IN RENAL TRANSPLANT RECIPIENTS RECEIVING MYCOPHENOLATE MOFETIL1,2Transplantation, 1995
- PLASMA EXCHANGE IN ACUTE RENAL ALLOGRAFT REJECTIONTransplantation, 1983